Welcome!

News Feed Item

EpiCast Report: Uveitis - Epidemiology Forecast to 2022

LONDON, Jan. 22, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:

EpiCast Report: Uveitis - Epidemiology Forecast to 2022

EpiCast Report: Uveitis - Epidemiology Forecast to 2022

Summary

Uveitis is a serious eye condition that often results in permanent vision damage due to frequent recurrence even after treatment. It consists of a group of diseases that present with inflammation of the uvea, can occur in one or both eyes, and may also affect the adjacent tissues such as the retina, optic nerve, and vitreous humor. Symptoms may include blurred vision, dark, floating spots in the vision, eye pain, redness of the eye, and sensitivity to light. Uveitis has a wide variety of causes such as autoimmune disorders, infectious agents, or toxins; however, the cause is often unknown for a significant proportion of the cases.

In 2012, GlobalData epidemiologists forecast the 6MM had 223,559 incident cases of uveitis, 75% of which (168,264 cases) occurred in the US. Incident cases in the 6MM are expected to increase slightly to 245,353 cases by 2022, at the rate of 0.97% per year. In 2012, the 6MM had 665,778 prevalent cases of uveitis, which will increase to 730,913 cases in 2022 at the rate of 0.98% per year. The US also had the largest proportion of prevalent cases in 2012 (53.69%, 357,483 cases) out of all markets covered in this analysis. The forecast further shows anterior uveitis is the most common form of uveitis and non-infectious uveitis is the most common etiology among the 6MM.

This forecast provides detailed, granular, and clinically relevant segmentations of uveitis cases. The segmentations will allow for improved understanding of the disease and the ability to focus on specific subgroups within the disease. The analysis is further strengthened by the adherence to the standard clinical reporting guidelines from the International Uveitis Study Group (IUSG) and Standardization of Uveitis Nomenclature (SUN) Working Group. Using standard guidelines across the 6MM allows for meaningful comparisons across the markets and ensures these results will be relevant in reference to future studies, as the use of the guidelines are becoming more common in epidemiological research.

Scope

- This report provides an overview of the risk factors, comorbidities and the global epidemiological trends for uveitis in the six major markets (6MM: US, France, Germany, Italy, Spain, and UK). The report also includes a 10-year forecast of incident and prevalent cases of uveitis segmented by age, sex, primary anatomical location of inflammation (anterior, intermediate, posterior, panuveitis), and by etiology (infectious, non-infectious, idiopathic). Incident cases are further segmented by course of disease (acute, recurrent, chronic) and by severity (mild, moderate, severe).
- The uveitis epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
- The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 6MM.

Reasons to buy

- Develop business strategies by understanding the trends shaping and driving the global uveitis market.
- Quantify patient populations in the global uveitis market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the patient segmentations that present the best opportunities for uveitis therapeutics in each of the markets covered.
- Identify the number of uveitis cases in each anatomical location category and in each etiology.

Table of Contents

1 Table of Contents 4
1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 8
2.1 Catalyst 8
2.2 Upcoming Reports 9
3 Epidemiology 10
3.1 Disease Background 10
3.2 Risk Factors and Comorbidities 11
3.2.1 Smoking increases risk of uveitis and increases complications 11
3.2.2 Juvenile idiopathic arthritis patients need regular ophthalmologic screenings 12
3.2.3 HLA-positive antigens are linked to certain types of uveitis 13
3.2.4 Uveitis is associated with various autoimmune, neurological, and infectious diseases 13
3.3 Global Trends 15
3.3.1 US 17
3.3.2 5EU 20
3.4 Forecast Methodology 22
3.4.1 Sources Used 25
3.4.2 Sources Not Used 30
3.4.3 Forecast Assumptions and Methods, Incident Cases 31
3.4.4 Forecast Assumptions and Methods, Prevalent Cases 32
3.4.5 Forecast Assumptions and Methods, Etiological and Anatomical Distribution 33
3.4.6 Forecast Assumptions and Methods, Course of Disease 36
3.4.7 Forecast Assumptions and Methods, Disease Severity 37
3.5 Epidemiological Forecast of Uveitis (2012-2022) 37
3.5.1 Incident Cases of Uveitis 37
3.5.2 Age-Specific Incident Cases of Uveitis 39
3.5.3 Sex-Specific Incident Cases 41
3.5.4 Age-Standardized Incidence Rates 42
3.5.5 Incident Cases by Anatomical Location 43
3.5.6 Incident Cases Segmented by Etiology 45
3.5.7 Course of Disease of Incident Uveitis Cases 48
3.5.8 Severity of Incident Uveitis Cases 50
3.5.9 Prevalent Cases of Uveitis 51
3.5.10 Age-Specific Prevalent Cases of Uveitis 53
3.5.11 Sex-Specific Prevalent Cases of Uveitis 54
3.5.12 Prevalent Cases by Anatomical Location 56
3.5.13 Prevalent Cases by Etiology 57
3.6 Discussion 59
3.6.1 Epidemiological Forecast Insight 59
3.6.2 Limitations of the Analysis 59
3.6.3 Strengths of the Analysis 61
4 Appendix 62
4.1 Bibliography 62
4.2 About the Authors 67
4.2.1 Epidemiologists 67
4.2.2 Reviewers 67
4.2.3 Global Director of Epidemiology and Health Policy 69
4.2.4 Global Head of Healthcare 69
4.3 About GlobalData 70
4.4 About EpiCast 70
4.5 Disclaimer 71

List of Tables

Table 1: Diseases Most Frequently Associated with Uveitis 14
Table 2: Distribution of Uveitis by Anatomical Location in Community and Referral Centers 20
Table 3: Distribution of Uveitis Cases by Anatomical Location of Inflammation, Europe 22
Table 4: IUSG/SUN Working Group Classification of Uveitis by Anatomical Location 23
Table 5: Clinical Classifications of Uveitis 23
Table 6: 6MM, Sources of Incidence and Prevalence of Uveitis in the 6MM 24
Table 7: Italy, Anatomy Classification Calculation 34
Table 8: US, Anatomical Locations of Uveitis for Incident and Prevalent Cases 36
Table 9: 6MM, Incident Cases of Uveitis, N (Column %), Select Years 2012-2022 38
Table 10: 6MM, Age-Specific Incident Cases of Uveitis, N (Row %), 2012 39
Table 11: 6MM, Sex-Specific Incident Cases of Uveitis, N (Row %), 2012 41
Table 12: 6MM, Incident Cases of Uveitis by Primary Anatomical Location of Inflammation, N (Row %), 2012 44
Table 13: 6MM, Incident Cases of Uveitis Segmented by Etiology and Age, N (Column %), 2012 46
Table 14: 6MM, Incident Cases of Uveitis Segmented by Etiology and Anatomical Location, N, 2012 47
Table 15: 6MM, Incident Cases of Uveitis by Course of Disease, N (Row %), 2012 48
Table 16: 6MM, Incident Cases of Uveitis by Severity of Disease, N, 2012 50
Table 17: 6MM, Prevalent Cases of Uveitis, N (Column %), Select Years, 2012-2022 52
Table 18: 6MM, Age-Specific Prevalent Cases of Uveitis, N (Row %), 2012 53
Table 19: 6MM, Sex-Specific Prevalent Cases of Uveitis, N (Row %), 2012 55
Table 20: 6MM, Prevalent Cases of Uveitis by Anatomical Location of Inflammation, N (Row %), 2012 56
Table 21: 6MM, Prevalent Cases of Uveitis Segmented by Etiology and Age, N (Column %), 2012 57
Table 22: 6MM, Prevalent Cases of Uveitis Segmented by Etiology and Anatomical Location, 2012 58

List of Figures

Figure 1: US, Age Distribution of Study Populations Compared with the US General Population 18
Figure 2: US, Sex-Ratio of Study Populations Compared with the US General Population 19
Figure 3: 6MM, Incident Cases of Uveitis, N, 2012-2022 38
Figure 4: 6MM, Age-Specific Incident Cases of Uveitis, N, 2012 40
Figure 5: 6MM, Sex-Specific Incident Cases of Uveitis, N, 2012 42
Figure 6: 6MM, Age-Standardized Uveitis Incidence, Cases per 100,000 Population, Men and Women, 2012 43
Figure 7: 6MM, Incident Cases of Uveitis by Primary Anatomical Location of Inflammation, N, 2012 45
Figure 8: 6MM, Incident Cases of Uveitis by Course of Disease, N, 2012 49
Figure 9: 6MM, Incident Cases of Uveitis by Severity of Disease, N, 2012 51
Figure 10: 6MM, Prevalent Cases of Uveitis, N, 2012-2022 52
Figure 11: 6MM, Age-Specific Prevalent Cases of Uveitis, N, 2012 54
Figure 12: 6MM, Sex-Specific Prevalent Cases of Uveitis, N, 2012 55

Read the full report:
EpiCast Report: Uveitis - Epidemiology Forecast to 2022
http://www.reportbuyer.com/pharma_healthcare/healthcare/epicast_report_uveitis_epidemiology_forecast_2022.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=General_Medicine_and_Specialty_Medicine

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]  
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
In his session at @DevOpsSummit at 20th Cloud Expo, Kelly Looney, director of DevOps consulting for Skytap, showed how an incremental approach to introducing containers into complex, distributed applications results in modernization with less risk and more reward. He also shared the story of how Skytap used Docker to get out of the business of managing infrastructure, and into the business of delivering innovation and business value. Attendees learned how up-front planning allows for a clean sep...
IoT is at the core or many Digital Transformation initiatives with the goal of re-inventing a company's business model. We all agree that collecting relevant IoT data will result in massive amounts of data needing to be stored. However, with the rapid development of IoT devices and ongoing business model transformation, we are not able to predict the volume and growth of IoT data. And with the lack of IoT history, traditional methods of IT and infrastructure planning based on the past do not app...
Enterprise architects are increasingly adopting multi-cloud strategies as they seek to utilize existing data center assets, leverage the advantages of cloud computing and avoid cloud vendor lock-in. This requires a globally aware traffic management strategy that can monitor infrastructure health across data centers and end-user experience globally, while responding to control changes and system specification at the speed of today’s DevOps teams. In his session at 20th Cloud Expo, Josh Gray, Chie...
Internet-of-Things discussions can end up either going down the consumer gadget rabbit hole or focused on the sort of data logging that industrial manufacturers have been doing forever. However, in fact, companies today are already using IoT data both to optimize their operational technology and to improve the experience of customer interactions in novel ways. In his session at @ThingsExpo, Gordon Haff, Red Hat Technology Evangelist, shared examples from a wide range of industries – including en...
In IT, we sometimes coin terms for things before we know exactly what they are and how they’ll be used. The resulting terms may capture a common set of aspirations and goals – as “cloud” did broadly for on-demand, self-service, and flexible computing. But such a term can also lump together diverse and even competing practices, technologies, and priorities to the point where important distinctions are glossed over and lost.
To get the most out of their data, successful companies are not focusing on queries and data lakes, they are actively integrating analytics into their operations with a data-first application development approach. Real-time adjustments to improve revenues, reduce costs, or mitigate risk rely on applications that minimize latency on a variety of data sources. Jack Norris reviews best practices to show how companies develop, deploy, and dynamically update these applications and how this data-first...
Intelligent Automation is now one of the key business imperatives for CIOs and CISOs impacting all areas of business today. In his session at 21st Cloud Expo, Brian Boeggeman, VP Alliances & Partnerships at Ayehu, will talk about how business value is created and delivered through intelligent automation to today’s enterprises. The open ecosystem platform approach toward Intelligent Automation that Ayehu delivers to the market is core to enabling the creation of the self-driving enterprise.
"At the keynote this morning we spoke about the value proposition of Nutanix, of having a DevOps culture and a mindset, and the business outcomes of achieving agility and scale, which everybody here is trying to accomplish," noted Mark Lavi, DevOps Solution Architect at Nutanix, in this SYS-CON.tv interview at @DevOpsSummit at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
"We're here to tell the world about our cloud-scale infrastructure that we have at Juniper combined with the world-class security that we put into the cloud," explained Lisa Guess, VP of Systems Engineering at Juniper Networks, in this SYS-CON.tv interview at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
"We're a cybersecurity firm that specializes in engineering security solutions both at the software and hardware level. Security cannot be an after-the-fact afterthought, which is what it's become," stated Richard Blech, Chief Executive Officer at Secure Channels, in this SYS-CON.tv interview at @ThingsExpo, held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA.
In his session at 20th Cloud Expo, Mike Johnston, an infrastructure engineer at Supergiant.io, discussed how to use Kubernetes to set up a SaaS infrastructure for your business. Mike Johnston is an infrastructure engineer at Supergiant.io with over 12 years of experience designing, deploying, and maintaining server and workstation infrastructure at all scales. He has experience with brick and mortar data centers as well as cloud providers like Digital Ocean, Amazon Web Services, and Rackspace. H...
All organizations that did not originate this moment have a pre-existing culture as well as legacy technology and processes that can be more or less amenable to DevOps implementation. That organizational culture is influenced by the personalities and management styles of Executive Management, the wider culture in which the organization is situated, and the personalities of key team members at all levels of the organization. This culture and entrenched interests usually throw a wrench in the work...
Consumers increasingly expect their electronic "things" to be connected to smart phones, tablets and the Internet. When that thing happens to be a medical device, the risks and benefits of connectivity must be carefully weighed. Once the decision is made that connecting the device is beneficial, medical device manufacturers must design their products to maintain patient safety and prevent compromised personal health information in the face of cybersecurity threats. In his session at @ThingsExpo...
SYS-CON Events announced today that Grape Up will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct. 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Grape Up is a software company specializing in cloud native application development and professional services related to Cloud Foundry PaaS. With five expert teams that operate in various sectors of the market across the U.S. and Europe, Grape Up works with a variety of customers from emergi...
Detecting internal user threats in the Big Data eco-system is challenging and cumbersome. Many organizations monitor internal usage of the Big Data eco-system using a set of alerts. This is not a scalable process given the increase in the number of alerts with the accelerating growth in data volume and user base. Organizations are increasingly leveraging machine learning to monitor only those data elements that are sensitive and critical, autonomously establish monitoring policies, and to detect...